Severe COVID-19 with acute respiratory distress syndrome (ARDS) in a sickle cell disease adult patient: case report
Open Access
- 29 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Pulmonary Medicine
- Vol. 21 (1), 1-5
- https://doi.org/10.1186/s12890-021-01412-x
Abstract
Background Sickle-cell anaemia is a widespread genetic disease prevalent worldwide among African and African-American populations. The pathogenesis is most often revealed by pulmonary conditions, including acute thoracic syndrome, which is affecting the life expectancy of these populations. The global spread of CoV2-SARS infection with a respiratory tropism, endothelial damages and procoagulant status endangers the SCD population. However, with only a few case reports, consequences of the Covid-19 pandemic on SCD population remain poorly known. Case presentation We report a case of a 33-year-old man with a history of homozygous SS homozygous sickle cell anemia who consulted on March 24, 2020 for febrile dyspnea 11 days after the onset of symptoms. A nasopharyngeal swab was positive for SARS-CoV-2. His respiratory status worsened rapidly in the emergency room and then in ICU leading to severe ARDS requiring intubation, curarization, and venovenous ECMO. Hematologically, severe hemolysis associated with major thrombocytopenia without documented spinal cord injury was noted. Several transfusion exchanges are performed. The evolution was finally slowly favorable and led to discharge from the intensive care unit and then from the hospital. Conclusions This case recalls the importance of an increased prevention policy against COVID-19among the SCD population. In addition, from a therapeutic point of view, it advocates (1) a high preventive anticoagulation from the outset according to the level of D-dimers (2) the use of venovenous ECMO in this particular case, whereas this technique has had rather disappointing results in acute chest syndromes. (3) Unexpectedly, our patient did not develop pulmonary arterial hypertension (PAH) and acute cor pulmonale (ACP), whereas this is a common feature of ARDS during SCD. These last two observations suggest a different pathophysiology of pulmonary disorders in SCD patients in the case of SARS COv2. It could be associated with marked hypoxemia secondary to pulmonary vascular vasodilation.Keywords
This publication has 21 references indexed in Scilit:
- Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the pastJournal of Clinical Virology, 2020
- Vaso‐occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID‐19)American Journal of Hematology, 2020
- COVID ‐19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patientAmerican Journal of Hematology, 2020
- Extracorporeal Life Support for Severe Acute Chest Syndrome in Adult Sickle Cell Disease: A Preliminary ReportCritical Care Medicine, 2019
- Pulmonary Vascular Dysfunction and Cor Pulmonale During Acute Respiratory Distress Syndrome in SicklersShock, 2016
- Pulmonary Artery Thrombosis during Acute Chest Syndrome in Sickle Cell DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Severe pandemic H1N1 and seasonal influenza in children and young adults with sickle cell diseaseBlood, 2010
- Effects of race and ethnicity on the incidence of venous thromboembolismThrombosis Research, 2009
- Pulmonary Hypertension and Cor Pulmonale during Severe Acute Chest Syndrome in Sickle Cell DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell DiseaseThe New England Journal of Medicine, 2000